Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasm Female × venetoclax × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 275 Leukemia, Lymphocytic, Chronic, B-Cell 95 Myelodysplastic Syndromes 55 Recurrence 47 Lymphoma, Non-Hodgkin 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Leukemia 38 Neoplasms 36 Lymphoma, Mantle-Cell 28 Leukemia, Myelomonocytic, Chronic 25 Multiple Myeloma 24 Lymphoma, Large B-Cell, Diffuse 24 Lymphoma, Follicular 20 Lymphoma 19 Hematologic Neoplasms 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15 Lymphoma, B-Cell, Marginal Zone 15 Burkitt Lymphoma 14 Leukemia, Biphenotypic, Acute 13 Myeloproliferative Disorders 11 Neoplasm, Residual 10 Lymphoma, B-Cell 9 Leukemia, Myeloid 9 Waldenstrom Macroglobulinemia 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, B-Cell 5 Breast Neoplasms 5 Blastic Plasmacytoid Dendritic Cell Neoplasm 5 Small Cell Lung Carcinoma 4

Interventions

Fulvestrant 2 venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡